Adopting MIGS devices
Research and practice are keys to successfully adding new devices and techniques
Howard Larkin
Published: Wednesday, March 1, 2017
Juan Battle MD
We have never lost an eye, we have always succeeded in Schlemmʼs canalFor example, in cannulating Schlemm’s canal, Dr Batlle has seen even glaucoma experts have problems. “Things all look the same - the pigment in front of Schwalbe’s looks like Schlemm’s, or it’s behind Schwalbe’s so you end up going higher, higher, higher because people want to put it way back in the trabecular meshwork. So have someone coach you,” he said. Fortunately, mistakes with MIGS devices usually are not serious, Dr Batlle added. “We have never lost an eye, we have always succeeded in Schlemmʼs canal. The worst that can happen is you don’t lower the intraocular pressure and you have to do it again.” Still, even a world-class surgeon like Dr Batlle needs practice. He recalls an Ivantis wetlab in Amsterdam introducing the Hydrus Microstent. “I was the only one there… I did 95 insertions of the Hydrus into cadaver eyes before I got it down.” Juan F Batlle: jbatlle55@gmail.com
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular
Long-awaited cellular therapies for corneal endothelial disease enter the clinic.
Balancing Innovation and Safety
Ensuring access to advanced cell therapies amid regulatory overhaul.
With Eyes on Its Future, ESCRS Celebrates Its Past
Winter Meeting offers opportunities to experiment with new concepts and formats.
Piecing Together a Solution
What is the best use of robotics and AI in cataract and refractive surgery?
Advances in Toric IOL Alignment
Biomorphometric approaches offer high precision and increase efficiency.
Library of Short Videos Complements Educational Offerings
Tackling Waste in Retinal Surgery
Reducing waste from intravitreal injections is an achievable goal.
The Modern Era of Refractive Surgery
New technologies for screening and treatment qualify more patients for intervention.
Monofocal Plus Finding the Balance
Enhanced monofocals may be the future standard of care in cataract patients.
Growing Options Optimise Outcomes in Cataract Surgery
Understanding the promise and potential problems of AI-based IOL formulas.